Sofinnova Partners: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer

MILAN, ITALY / ACCESSWIRE / September 8, 2022 / AAVantgarde Bio, a clinical stage Milan-based international biotechnology start-up that has developed proprietary Adeno-Associated Viral (AAV) vector platforms

Related Keywords

Italy ,Milan ,Lombardia ,London ,City Of ,United Kingdom ,Paola Pozzi ,Julia Wilson ,Kostenloser Wertpapierhandel ,Alberto Auricchio ,Naveed Shams ,Ram Palanki ,Aavantgarde Bio ,Tigem Telethon Institute Of Genetics ,University Of Wales ,Jw Communications ,Bangor University ,Sofinnova Partner Telethon Fund ,Arthur Andersen ,Adeno Associated Viral ,Natalia Misciattelli ,Chief Executive Officer ,Chief Business Officer ,Senior Vice President ,Freeline Therapeutics ,Sofinnova Partner Telethon ,Professor Alberto Auricchio ,Marine Microbiology ,General Electric Healthcare ,Chief Development ,Medical Officer ,Telethon Institute ,Sofinnova ,Partners ,Avantgarde ,Ppoints ,Natalia ,Isciattelli ,Chief ,Executive ,Officer ,